April 15, 2109
The University of Pittsburgh announced that Pitt innovators were issued three U.S. patents in March 2019.
Featured Patent: U.S. 10,233,201 “Class of HDAC Inhibitors”
Neil Hukriede, Professor and Vice Chair of the Department of Developmental Biology, and colleagues, have identified a novel class of histone deacetylase (HDAC) inhibitors which cause expansion of renal progenitor cells during embryonic development. They have shown in experiments that this accelerates renal recovery when given after acute kidney injury. For more information on this innovation, contact Maria Vanegas at firstname.lastname@example.org.
Below is a list of all patents issued to Pitt innovators in February 2019. To search the database of all Pitt innovations available for licensing, click here.
|10,222,374||B-Cell Antigen Presenting Cell Assay||Rakesh Sindhi; Chethan Kumar||Maria Vanegas||Licensed|
|10,233,201||Class of HDAC Inhibitors Expands the Renal Progenitor Cells Population and Improves the Rate of Recovery From Acute Kidney injury||Neil Hukriede; Lee McDermott; Billy Day||Maria Vanegas||Available for Licensing|
|10,239,071||Graft Devices and Methods of Use||David Vorp; William Wagner; Lorenzo Soletti; Mohammed El-Kurdi; Andrew Ziegler; Jonathan McGrath; Christopher Flaherty||Alex Ducruet||Available for Licensing|